Accurate results. Trusted services. Your laboratory.

Welcome to your US-based clinical sequencing laboratory, where patient care comes first. We understand the importance of reliable test results, and that's why we've made it our mission to provide the highest standard of laboratory services.

The laboratory

At our state-of the art NGS laboratory, precision, and accuracy is our primary focus. With a team of experienced professionals and cutting-edge technology, we are committed to delivering results you can trust.

Our laboratory is situated in Atlanta, a significant hub for the pharmaceutical and diagnostic industry. The recently acquired facilities are in proximity to the largest airport in the United States, the Atlanta airport, facilitating expedited transportation of blood samples.

“Welcome to our modern US-based NGS laboratory. Our ambition is to provide accurate and reliable results to support the healthcare needs of our communities. Let's work together to improve patient outcomes and lead the way in laboratory excellence.”

- John Murad, Vice President and General Manager, North America

Devyser's laboratory

11660 Alpharetta Highway
Suite 700, Office 790
Roswell, Georgia 30076

United States

News IVDR | March 1, 2023

We have launched our first IVDR-certified product

Today we launched our first IVDR-certified product. Devyser Compact is a rapid genetic test for prenatal chromosome testing and the first of its type to be approved under the new more comprehensive regulation that came into force in May 2022. The original product was first launched in 2006 and is today the golden standard in prenatal testing in many European countries.

Find out more

Webinar on-demand | February 16, 2023

Post-transplant monitoring: The future of chimerism testing

News | January 25-26, 2023

We are attending the Festival of Genomics & Biodata!

Podcast | December 6, 2022

Collaborations and homebrew assays by Dan Hauzenberger & Turid Sundin Carlsson

Latest from the Devyser blog

View all

New more sensitive diagnostics protect transplanted kidney

With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis

Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...

Assessment of Chimerism Testing by Next Generation Sequencing

Relapse of the underlying malignant disease is a major complication after hematopoietic stem cell...